Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Andrews Audrey T.
   2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [THC] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
SVP and General Counsel
(Last)
(First)
(Middle)
1445 ROSS AVENUE, SUITE 1400		 3. Date of Earliest Transaction (Month/Day/Year)
02/28/2014
(Street)

DALLAS, TX 75202		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock (1) (2) 02/28/2014   M   4,167 A (3) 9,836 D  
Common Stock 02/28/2014   F   1,140 (4) D $ 44.12 8,696 D  
Common Stock (5) 02/28/2014   M   3,392 A (3) 12,088 D  
Common Stock 02/28/2014   F   928 (4) D $ 44.12 11,160 D  
Common Stock (6) 02/28/2014   M   3,392 A (3) 14,552 D  
Common Stock 02/28/2014   F   928 (4) D $ 44.12 13,624 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
2012 February Restricted Stock Units (2) 02/28/2014   M     4,167   (2)   (2) Common Stock 4,167 $ 0 4,166 D  
2013 February Performance-Based Restricted Stock Units (5) 02/28/2014   M     3,392   (5)   (5) Common Stock 3,392 $ 0 6,784 D  
2013 February Restricted Stock Units (6) 02/28/2014   M     3,392   (6)   (6) Common Stock 3,392 $ 0 6,784 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Andrews Audrey T.
1445 ROSS AVENUE
SUITE 1400
DALLAS, TX 75202		       SVP and General Counsel  

Signatures

 /s/ Jeffrey S. McFall, Attorney-in-Fact for Audrey T. Andrews   03/04/2014
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) All historical share data in this Form 4 have been restated to reflect a one-for-four reverse stock split effective as of October 11, 2012.
(2) As previously reported, on February 29, 2012, the reporting person received a grant of 12,500 restricted units that vest ratably on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 28, 2013, resulting in the vesting and settlement of 4,167 shares of common stock. The second anniversary occurred on February 28, 2014, resulting in the vesting and settlement of 4,167 shares of common stock, as shown in Table I. The remaining 4,166 restricted units are shown in Table II, which are scheduled to vest on February 28, 2015. Restricted units are settled in shares of the Company's common stock upon vesting.
(3) Restricted units convert into common stock on a one-for-one basis.
(4) Shares withheld for payment of taxes upon vesting of restricted units in accordance with Rule 16b-3.
(5) As previously reported, on February 28, 2013, the reporting person received a grant of 10,176 performance-based restricted units that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending December 31, 2013. The performance metric was met; therefore, these restricted units vest ratably on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 28, 2014, resulting in the vesting and settlement of 3,392 shares of common stock, as shown in Table I. The remaining 6,784 performance restricted units are shown in Table II, of which 3,392 are scheduled to vest on February 28, 2015 and 3,392 are scheduled to vest on February 28, 2016. Performance-based restricted units are settled in shares of the Company's common stock upon vesting.
(6) As previously reported, on February 28, 2013, the reporting person received a grant of 10,176 restricted units that vest ratably on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 28, 2014, resulting in the vesting and settlement of 3,392 shares of common stock, as shown in Table I. The remaining 6,784 restricted units are shown in Table II, of which 3,392 are scheduled to vest on February 28, 2015 and 3,392 are scheduled to vest on February 28, 2016. Restricted units are settled in shares of the Company's common stock upon vesting.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.